Salute e Benessere

Global Curtains and Window Blinds Market Size Driven by 3.24% CAGR, Growth…

Curtains and Window Blinds Market: Overview Curtains and Window Blinds Market: Overview The curtains and window blinds industry refers to the production, distribution, and sale of curtains and window blinds. They are used for decorative and functional purposes in several settings including commercial, residential, and institutional units. Curtains are hung on windows and provide the residents with privacy along with performing more functional duties such as controlling the amount of...
PR Newswire
16/06/2023

Monthly information regarding the total number of voting rights and total number…

Monthly information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2023 (Article 223-16 of the General Regulations of theAutorité des Marchés Financiers ) Market : NYSE Euronext ParisISIN Code: FR 0010417345 Date Total number of shares Total number of voting rights05/31/202394,198,504 Total gross of voting rights: 94,198,504 Total net* of voting rights: 94,047,253 ...
Nasdaq GlobeNewswire
16/06/2023

Apollo Neuro Expands User Base Internationally With UK Launch

"Healf, which focuses on high-quality health brands and has a panel of leading experts to endorse each product, is the perfect partner for our first international launch," says Kathryn Fantauzzi, Co-Founder and CEO of Apollo Neuro. "We look forward to growing our loyal user base by making the Apollo wearable more accessible for people living in the UK." "Healf, which focuses on high-quality health brands and has a panel of leading experts to endorse each product, is the…
PR Newswire
16/06/2023

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Regulated InformationLeuven, BELGIUM, Boston, MA, US – June 16 , 2023 – 7 .00 PM CETOxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, today announced that, pursuant to Belgian Transparency legislation 1it has received a...
Nasdaq GlobeNewswire
16/06/2023

Anesthesia Equipment Market worth $11.0 billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=52398227 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=52398227 Browse in-depth TOC on "Anesthesia Equipment Market" 130 - Tables 50 - Figures 190 - Pages Anesthesia Equipment Market Scope: Anesthesia devices accounted for the largest share of the anesthesia equipment market. Based on the type, the anesthesia equipment market is...
PR Newswire
16/06/2023

Eurobio Scientific: all resolutions approved at the Annual General Meeting

Eurobio Scientific: all resolutions approved at the Annual General MeetingThe Board of Directors appoints a new governanceParis, 16June 2023 – 5:45pmEurobio Scientific(FR0013240934, ALERS, PEA-PME eligible), a leading French group in in vitro specialty medical diagnostics and life sciences, held its ordinary and extraordinary general meeting of shareholders on 13 June 2023.At the date of the meeting, the total number of shares with voting rights was...
Nasdaq GlobeNewswire
16/06/2023

Fibromyalgia Treatment Market to Reach $4.6 Billion, Globally, by 2032 at 4.0%…

Download Sample Copy- https://www.alliedmarketresearch.com/request-sample/13726 Download Sample Copy-https://www.alliedmarketresearch.com/request-sample/13726 Prime Determinants of Growth- The fibromyalgia treatment market is experiencing growth due to several key factors, such as the significant prevalence of fibromyalgia among the population, a surge in awareness regarding fibromyalgia and its treatment, and enhanced access to generic medications for fibromyalgia treatment...
PR Newswire
16/06/2023

TG ImmunoPharma Announces FDA Clearance for Clinical Trial of TGI-6 Bispecific…

"We are thrilled to receive FDA clearance for the clinical trial of TGI-6," said Professor Zhigang Tian, founder of TGI and member of the Chinese Academy of Engineering and the Academia Europaea. "TGI-6 has demonstrated superior anti-tumor activity and safety in preclinical studies. We have great confidence in its potential as a novel therapy for solid tumors." "We are thrilled to receive FDA clearance for the clinical trial of TGI-6," said ProfessorZhigang Tian…
PR Newswire
16/06/2023

Kantar BrandZ™ Names Hisense within the Top 10 Chinese Global Brand Builders…

The two keywords that test the quality of a brand's global expansion are self-owned brands and high-end brands going overseas. The fact that it has been named as one of the top 10 global brands for seven consecutive years is due to Hisense's long-term commitment to developing the Hisense International Brand, as well as manufacturing cutting-edge products. Over the years, it has always insisted on the "localization" of R&D, production, and marketing to meet local market demand with…
PR Newswire
16/06/2023

Kindra Continues Rapid Growth As Leading Destination for Menopause Solutions

"The UK has been at the forefront of the menopause conversation, leading the charge in addressing this crucial women's health issue. As a result, we have seen consistent, organic growth and interest in the brand from women based in the UK. Even prior to our launch, - the massively unmet need was clear," stated Kindra Founder and CEO Catherine Balsam-Schwaber. "We are so happy to be expanding our footprint and on this strong trajectory to support more women. We believe every woman…
PR Newswire
16/06/2023

uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

uniQure N.V.(NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the grant of inducement equity awards to Jeannette Potts, the Company's newly hired Chief Legal and Compliance Officer, and other newly hired employees. The inducement awards to Ms. Potts consist of a non-qualified option to purchase 81,300 ordinary shares of the Company and 47,100 restricted share units. The option has an exercise price of...
Nasdaq GlobeNewswire
16/06/2023

Tessa Therapeutics Announces Positive Results from CD30 CAR-T Combination Study…

Objective response observed in 9/10 patients and complete response observed in 7/10 patients No patients proceeded to autologous stem cell transplant (ASCT) as of data cut-off Well tolerated safety profile - no Grade 3 or above CRS, no neurotoxicity SINGAPORE, June16, 2023(GLOBE NEWSWIRE) --Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, today...
Nasdaq GlobeNewswire
16/06/2023

FORESEE PHARMACEUTICALS ANNOUNCES POSTER PRESENTATION AND PARTICIPATION AT THE…

The poster entitled: "THERAPEUTIC EFFECT OF A NOVEL MMP-12 INHIBITOR IN A CARDIAC SARCOIDOSIS MOUSE MODEL" is the result of a collaboration with academic clinical experts in the area of sarcoidosis and focuses on FP-020, a follow-on oral MMP-12 inhibitor which has completed IND-enabling development and poised for Phase 1 studies in 2023 and Phase 2 studies in 2024. The poster entitled: "THERAPEUTIC EFFECT OF A NOVEL MMP-12 INHIBITOR IN A CARDIAC SARCOIDOSIS MOUSE MODEL" is…
PR Newswire
16/06/2023

Cholesgen to enter into a drug discovery collaboration and licensing option…

High levels of cholesterol are a major risk factor for atherosclerotic cardiovascular disease (ASCVD). ASCVD remains a leading cause of death worldwide, despite advances in preventive interventions. High levels of cholesterol are a major risk factor for atherosclerotic cardiovascular disease (ASCVD). ASCVD remains a leading cause of death worldwide, despite advances in preventive interventions. "This is an important collaboration for AstraZeneca, led by deep scientific expertise and a…
PR Newswire
16/06/2023

Annual Congress 2023 of the European Academy of Allergy and Clinical Immunology…

Sputum samples from the athletes were analysed and compared with samples from controls who engaged in less than six hours of sports per week. The results showed that the athletes had significantly higher levels of carbon-loaded alveolar macrophages (AMs) in their sputum samples compared to the control group. Similarly, the number of particles in macrophages and the percentage of area occupied by black carbon were also significantly increased in athletes compared to controls. These findings can…
PR Newswire
16/06/2023

Cantourage UK, Leading Medical Cannabis Company Forms Partnership with Premier…

Plantations Cérès is a family-run company based in St-Liguori, Québec. With more than 20 years of growing experience and with the help of state-of-the-art technologies, the growers are dedicated to the cultivation of high-quality "Craft" cannabis. The guiding principle here is quality over quantity. The focus on distributing small batches from controlled cultivation pays off in consistently high quality. Their collaboration with Cantourage UK is designed to bring multiple strains of…
PR Newswire
16/06/2023

SKF signs EUR 800 million multicurrency revolving credit facility

The facility is supported by a group of ten leading global and regional banks. Bank of America and SEB acted as joint Co-ordinating Mandated Lead Arrangers and Bookrunners in the process. In addition, Bank of China, BNP Paribas, Citibank, Deutsche Bank, Handelsbanken, HSBC, J.P. Morgan, and Nordea, joined the facility as Mandated Lead Arrangers and Bookrunners. The facility is supported by a group of ten leading global and regional banks. Bank of America and SEB acted as joint Co-ordinating...
PR Newswire
16/06/2023

Global Medication Adherence Technologies Market Set for Unprecedented Growth…

Download PDF Sample here: https://dataintelo.com/request-sample/?reportId=425559 Download PDF Sample here: https://dataintelo.com/request-sample/?reportId=425559 Key Takeaways from the Medication Adherence Technologies Market Report: The Growing Unmet Needs and the Trend towards Advanced Medication Adherence Technology Medication adherence, or the extent to which a person follows a prescribed medication regimen, is a major concern for global healthcare. Failure to adhere to...
PR Newswire
16/06/2023

Cantourage UK Partners with Portocanna to Improve Affordable Medical Cannabis…

Portocanna, located in Santarém, Portugal, maintains a firm commitment to leveraging the health benefits of cannabis. Their dedicated team of professional's work with carefully selected cultivators to ensure delivery of high-quality cannabis products, consistently. Portocanna, located in Santarém,Portugal, maintains a firm commitment to leveraging the health benefits of cannabis. Their dedicated team of professional's work with carefully selected cultivators to ensure delivery of...
PR Newswire
16/06/2023

Global Respiratory Devices and Equipment Market Report: Comprehensive Analysis…

This comprehensive market research report provides a detailed analysis of global respiratory devices and equipment, segmenting the market by therapeutic devices, monitoring devices, diagnostic devices, consumables & accessories, and application. Furthermore, the report divides by end user into hospitals, clinics, home care, and ambulatory surgical centers, followed by regional segmentation in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. This…
PR Newswire
16/06/2023

Global Medical Imaging Technologies Market Projected to Grow as Healthcare…

Download PDF Sample here: https://dataintelo.com/request-sample/?reportId=425565 Download PDF Sample here: https://dataintelo.com/request-sample/?reportId=425565 Market by Type: X-ray, MRI, Ultrasound, CT, Nuclear Medicine, PET With advancements in technology, key market players are focusing on the development of innovative and advanced imaging techniques, such as X-ray, MRI, ultrasound, CT, nuclear medicine, and PET scans, to gain a competitive edge and address the increasing...
PR Newswire
16/06/2023

Bavarian Nordic Reports 12-Month Durability Data from a Phase 2 Clinical Trial…

COPENHAGEN, Denmark, June 16, 2023– Bavarian Nordic A/S (OMX: BAVA) announced today the results of a 12-month follow-up analysis from a subset of subjects enrolled in a Phase 2 clinical trial of ABNCoV2, a VLP-based, non-adjuvanted COVID-19 booster vaccine candidate.Results from 36 subjects, who had not received a booster dose outside of the trial and had no reports of COVID-19 disease or a positive PCR results for SARS-CoV-2 since vaccination in the study, showed that 12 months post the...
Nasdaq GlobeNewswire
16/06/2023

Sequana Medical wins Best Technology Award for alfapump® at European Mediscience…

Ghent, Belgium – 16 June2023– Sequana Medical NV (Euronext Brussels: SEQUA)(the " Company " or " SequanaMedical "), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, today announces that itsalfa pump has won the 'Best Technology' Award at the European Mediscience Awards in London last night.The European Mediscience Awards event is the largest annual gathering of private and publicly quoted healthcare, biotech and life...
Nasdaq GlobeNewswire
16/06/2023

FDA approves Roche's Columvi, the first and only bispecific antibody with a…

Pivotal study showed durable responses, with a 56% overall response rate, a 43% complete response (remission) rate and a median duration of response of 1.5 years (18.4 months) 1 Given over a fixed period of time, Columvi provides patients with a treatment end date and potential time off treatment Columvi is part of Roche's industry-leading portfolio of T-cell engaging bispecific antibodies in non-Hodgkin lymphoma, which also includes the recently approved Lunsumioto treat...
Nasdaq GlobeNewswire
16/06/2023
Altri  Comunicati